US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Global X Genomics & Biotechnology ETF

65.13

-1.6430-2.46%

Post-market: 65.00-0.1270-0.20%19:30 EDT

Volume:41.52K

Turnover:2.70M

Market Cap:92.79M

PE:- -

High:66.06

Open:66.06

Low:64.03

Close:66.77

52wk High:66.88

52wk Low:36.00

Shares:1.42M

Float Shares:1.42M

Volume Ratio:1.41

T/O Rate:2.91%

Dividend:0.65

Dividend Rate:0.99%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna Expands Respiratory Vaccine Pipeline With New RSV/hMPV Trial in Older Adults

Natera, Inc. : Citigroup Raises Target Price to $365 from $315

THOMSON REUTERS

Moderna Inc. Stock Rises 5.1%, Outperforms Peers

Illumina Prices $300 Million Notes Offering Due 2029

Natera, Inc. : Stephens Raises Target Price to $350 from $305

THOMSON REUTERS

Natera Partners with Kupando Therapeutics to Use Latitude ctDNA Test in Phase 1 Skin Cancer Trial

Natera to Support New Clinical Trial Assessing Ctdna Dynamics with Latitude™ in Advanced Skin Cancers

THOMSON REUTERS

Natera, Inc. : Piper Sandler Raises Target Price to $363.50 from $249

THOMSON REUTERS

Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares

Illumina Ajukan Form 3; Chief Legal Officer Julie Ann Coletti Laporkan Kepemilikan Manfaat Awal

Twist Bioscience Director Robert Chess Disposes of Common Shares Worth $2.041.010,13

Illumina Building Clinical Momentum Amid Fading Competition, RBC Capital Markets Says

MT Newswires Live

Neurogene Advances Rett Gene Therapy Program and Extends Cash Runway to 2029

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/GNOM/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GNOM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","market":"US","secType":"STK","nameCN":"Global X Genomics & Biotechnology ETF","latestPrice":65.127,"timestamp":1787601600000,"preClose":66.77,"halted":0,"volume":41524,"hourTrading":{"tag":"盘后","latestPrice":65,"preClose":65.127,"latestTime":"19:30 EDT","volume":279,"amount":18140.437,"timestamp":1787614206811,"change":-0.127,"changeRate":-0.00195,"amplitude":0.001996},"delay":0,"changeRate":-0.02460685936797964,"floatShares":1424771,"shares":1424771,"eps":0,"marketStatus":"Closed","change":-1.643,"latestTime":"08-24 16:00:00 EDT","open":66.06,"high":66.06,"low":64.0301,"amount":2702159.7666,"amplitude":0.030401,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787644800000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":66.77,"sharesOutstanding":1094672,"nav":66.56,"aum":94832765.15,"dividendRate":0.009945,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":66.06,"preClose":66.77,"latestTime":"09:29 EDT","volume":502,"amount":33166.99944,"timestamp":1787578199999,"change":-0.71,"changeRate":-0.010634,"amplitude":0.001647},"postHourTrading":{"tag":"盘后","latestPrice":65,"preClose":65.127,"latestTime":"19:30 EDT","volume":279,"amount":18140.437,"timestamp":1787614206811,"change":-0.127,"changeRate":-0.00195,"amplitude":0.001996},"volumeRatio":1.406659,"impliedVol":0.3313,"impliedVolPercentile":0.844},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","floatShares":1424771,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.406659,"shares":1424771,"dividePrice":0.6477,"high":66.06,"amplitude":0.030401,"preClose":66.77,"low":64.0301,"week52Low":36,"pbRate":"--","week52High":66.88,"institutionHeld":0,"latestPrice":65.127,"eps":0,"divideRate":0.009945,"volume":41524,"delay":0,"ttmEps":0,"open":66.06,"prevYearClose":45.4562,"prevWeekClose":66.77,"prevMonthClose":54.17,"prevQuarterClose":56.834,"fiveDayClose":59.09,"twentyDayClose":53.6914,"sixtyDayClose":49.5125},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNOM\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"GNOM","amount":0.057885,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"GNOM","amount":0.591211,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"GNOM","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":4,"toFactor":1,"ratio":4},{"date":"2025-06-27","symbol":"GNOM","amount":0.00828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"market":"US","date":"2021-12-30","symbol":"GNOM","amount":0.006507,"defaultRemindTime":1640874600000,"name":"Global X Genomics & Biotechnology ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNOM\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.032402,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.006507,"currency":"USD"},{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00828,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.591211,"currency":"USD"},{"executeDate":"2026-06-29","recordDate":"2026-06-29","paymentDate":"2026-07-07","value":0.057885,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNOM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNOM\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659166082","title":"Moderna Expands Respiratory Vaccine Pipeline With New RSV/hMPV Trial in Older Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166082","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166082?lang=en_us&edition=fundamental","pubTime":"2026-08-14 00:30","pubTimestamp":1786638638,"startTime":"0","endTime":"0","summary":"Moderna ($MRNA) announced an update on their ongoing clinical study. ModernaTX, Inc. has launched a new early-stage trial called “A Phase 1, Random...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/moderna-expands-respiratory-vaccine-pipeline-with-new-rsv-hmpv-trial-in-older-adults?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/moderna-expands-respiratory-vaccine-pipeline-with-new-rsv-hmpv-trial-in-older-adults?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGHT","BK4501","BK4585","BK4534","BK4551","BK4532","GNOM","BK4139","IDNA","MRNX","BK4533","BK4588","BK4568","WDNA","BK4548","MRNA","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659153712","title":"Natera, Inc. : Citigroup Raises Target Price to $365 from $315","url":"https://stock-news.laohu8.com/highlight/detail?id=2659153712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659153712?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:33","pubTimestamp":1786617184,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nFWN44A0LZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171311.SGD","LU2264538146.SGD","LU2065171402.SGD","HELX","LU0345770993.USD","LU0053671581.USD","LU0963586101.USD","LU0106261612.USD","LU0345770308.USD","NTRA","LU1064131342.USD","LU1988902786.USD","BK4139","GNOM","LU2065169927.USD","LU2065170008.USD","LU2065731478.USD","LU0012050646.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188699","title":"Moderna Inc. Stock Rises 5.1%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188699","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188699?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:34","pubTimestamp":1786566840,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rallied 5.1% to $63.67 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.5% to 26,588.49 and the Dow Jones Industrial Average remaining mostly unchanged at 53,770.27.This was the stock's fourth consecutive day of gains.Moderna Inc. closed 25.6% below its 52-week high of $85.60, which the company reached on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.4% to $260.86, Pfizer Inc. fell 1.2% to $26.31, and Gilead Sciences Inc. rose 0.07% to $135.87.Trading volume totaled 6.0 million, compared to the 50-day average of 7.3 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","LU0965508806.USD","LU1057294990.SGD","LU1066051498.USD","BK4550","BK4551","BK4585","LU2112291526.USD","LU1037948897.HKD","TMED","BMED","BIB","LU1585245621.USD","MRNX","GILD","LU0289739699.SGD","IBBQ","LU1037948541.HKD","LU1674673691.USD","BK4566","LU0320765992.SGD","TBXU","LGHT","BBH","LU2087621335.USD","LU1061106388.HKD","LU1430594728.SGD","IE00BKVL7J92.USD","LU0823416689.USD","LU1934455194.USD","IDNA","WDNA","IE0002270589.USD","GNOM","BK4588","LU0882574055.USD","IE00B19Z3581.USD","MRNA","LU0889565916.HKD","LU2324357040.USD","MRNY","IE00BZ1G4Q59.USD","LU1674673428.USD","LU1023059063.AUD","BK4501","BK4139","IE00BSNM7G36.USD","SG9999015978.USD","BK4532","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972920","title":"Illumina Prices $300 Million Notes Offering Due 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972920","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972920?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:06","pubTimestamp":1786536384,"startTime":"0","endTime":"0","summary":"Illumina prices $300 million notes offering due 2029Illumina priced USD 300 million of 4.95% notes due 2029 under an underwriting agreement led by J.P. Morgan, Citigroup.Closing expected Aug. 17, subj","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL4K9VGL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU2360032135.SGD","BK4535","FTXO","LU0203345920.USD","LU0310800965.SGD","LU0072461881.USD","LU0314106906.USD","BK4585","LU2462157665.USD","BK4504","LU0980610538.SGD","LU1668664300.SGD","LU2236285917.USD","LU0106831901.USD","LU1162221912.USD","LU1201861249.SGD","LU1244550221.USD","LU2125154935.USD","ILMN","IE00BSNM7G36.USD","LU0029874061.USD","GNMX","LU1506573853.SGD","LU0098860793.USD","IYF","BK4588","BK4121","LU1074936037.SGD","BK4548","BK4207","LU0477156953.USD","LU0648001328.SGD","LU2125154778.USD","LU1267930227.SGD","TFNS","LU0170899867.USD","LU1791807156.HKD","LU2417539215.USD","LU0162691827.USD","LU1244550577.SGD","LU0203347892.USD","LU2456880835.USD","GNOM","LU0128526141.USD","LU0320765646.SGD","BK4566","LU0052756011.USD","LU1366192091.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658118976","title":"Natera, Inc. : Stephens Raises Target Price to $350 from $305","url":"https://stock-news.laohu8.com/highlight/detail?id=2658118976","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658118976?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:21","pubTimestamp":1786530064,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490FB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065171402.SGD","HELX","LU2264538146.SGD","LU0963586101.USD","LU1064131342.USD","LU0053671581.USD","LU0345770308.USD","LU0012050646.USD","BK4139","NTRA","LU2324357040.USD","LU2065169927.USD","GNOM","LU2065731478.USD","LU2065171311.SGD","LU0106261612.USD","LU2065170008.USD","LU0345770993.USD","LU1988902786.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658975282","title":"Natera Partners with Kupando Therapeutics to Use Latitude ctDNA Test in Phase 1 Skin Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2658975282","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658975282?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:01","pubTimestamp":1786528893,"startTime":"0","endTime":"0","summary":"Natera partners with Kupando Therapeutics to use Latitude ctDNA test in Phase 1 skin cancer trialNatera entered a collaboration with Kupando Therapeutics to support a Phase 1 trial of immunotherapy ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLbT5KLV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0963586101.USD","NTRA","LU2065731478.USD","LU2065169927.USD","BK4139","LU0012050646.USD","LU0053671581.USD","LU1064131342.USD","LU2264538146.SGD","LU2065171311.SGD","LU0345770308.USD","LU0345770993.USD","HELX","LU1988902786.USD","LU2324357040.USD","LU0106261612.USD","GNOM","LU2065170008.USD","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658975416","title":"Natera to Support New Clinical Trial Assessing Ctdna Dynamics with Latitude™ in Advanced Skin Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658975416","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658975416?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:00","pubTimestamp":1786528800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA74PDL6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0963586101.USD","BK4139","LU0106261612.USD","LU0012050646.USD","LU0053671581.USD","LU0345770308.USD","LU2065171311.SGD","GNOM","LU1064131342.USD","LU2065171402.SGD","LU2324357040.USD","NTRA","LU1988902786.USD","LU2065731478.USD","LU0345770993.USD","LU2065169927.USD","HELX","LU2065170008.USD","LU2264538146.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658975588","title":"Natera, Inc. : Piper Sandler Raises Target Price to $363.50 from $249","url":"https://stock-news.laohu8.com/highlight/detail?id=2658975588","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658975588?lang=en_us&edition=fundamental","pubTime":"2026-08-12 17:49","pubTimestamp":1786528145,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4490C2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","LU0053671581.USD","LU0345770308.USD","LU2065170008.USD","LU0963586101.USD","LU1988902786.USD","LU0345770993.USD","LU0012050646.USD","LU2065169927.USD","LU2264538146.SGD","LU2065171402.SGD","LU0106261612.USD","HELX","NTRA","LU2065731478.USD","BK4139","GNOM","LU2065171311.SGD","LU1064131342.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658949165","title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2658949165","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658949165?lang=en_us&edition=fundamental","pubTime":"2026-08-12 06:23","pubTimestamp":1786487005,"startTime":"0","endTime":"0","summary":"Guardant Health Chief Commercial Officer Chris Freeman disposes of $ 10.75 million in common sharesGuardant Health Chief Commercial Officer Chris Freeman exercised stock options for 63,605 shares on A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL4khYKk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","GDOC","LU0109394709.USD","BK4585","EKG","FFOX","PTH","GNMX","GNOM","HELX","BK4551","LU0889565916.HKD","BK4535","LU0320765992.SGD","BK4588","GH","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658283943","title":"Illumina Ajukan Form 3; Chief Legal Officer Julie Ann Coletti Laporkan Kepemilikan Manfaat Awal","url":"https://stock-news.laohu8.com/highlight/detail?id=2658283943","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658283943?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:28","pubTimestamp":1786480129,"startTime":"0","endTime":"0","summary":"Illumina ajukan Form 3; Chief Legal Officer Julie Ann Coletti laporkan kepemilikan manfaat awalIllumina mengajukan Form 3 untuk Julie Ann Coletti sebagai Chief Legal Officer, dengan tanggal kejadian 0","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL1D0fxf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GNOM","BK4535","LU0128526141.USD","BK4534","GNMX","ILMN","BK4548","BK4588","LU0029874061.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658419948","title":"Twist Bioscience Director Robert Chess Disposes of Common Shares Worth $2.041.010,13","url":"https://stock-news.laohu8.com/highlight/detail?id=2658419948","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658419948?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:06","pubTimestamp":1786478789,"startTime":"0","endTime":"0","summary":"Twist Bioscience Director Robert Chess disposes of common shares worth $2.041.010,13Direktur Robert Chess mengeksekusi opsi, memperoleh 18.417 saham Twist Bioscience pada harga USD 11,89 per saham.Pad","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL7QKKdC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Twist Bioscience Director Robert Chess Disposes of Common Shares Worth $2.041.010,13","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDNA","BK4588","GNOM","BK4139","IDNA","ARKG","TWST","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658197479","title":"Illumina Building Clinical Momentum Amid Fading Competition, RBC Capital Markets Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658197479","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658197479?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:58","pubTimestamp":1786460297,"startTime":"0","endTime":"0","summary":"Illumina  is building clinical momentum as competitive concerns surrounding the company are fading, RBC Capital Markets said in a note Monday.The company's clinical sequencing revenue could grow at a durable mid-teens rate, driven by volume growth in oncology and easing pricing headwinds, according to the note.RBC said that while customers are expected to evaluate competitive sequencing instruments, Illumina will likely retain its clinical market share.Sequencing instrument sales could decline double digits in 2027 as they face more headwinds than previously expected, but clinical sequencing and sequencing services could offset this decline, the firm added.RBC Capital Markets has an outperform rating and a $230 price target on the stock.Price: 191.86, Change: +0.07, Percent Change: +0.04","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0310800379.SGD","BK4535","LU0029874061.USD","LU0128525929.USD","LU0128526141.USD","BK4548","BK4207","GSIB","BK4121","BK4585","GNOM","LU0708994859.HKD","LU0029864427.USD","BK4534","LU1267930573.SGD","BK4588","ILMN","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658657916","title":"Neurogene Advances Rett Gene Therapy Program and Extends Cash Runway to 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2658657916","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658657916?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:01","pubTimestamp":1786456868,"startTime":"0","endTime":"0","summary":"Neurogene ( ($NGNE) ) just unveiled an announcement. Neurogene reported strong progress in its NGN-401 gene therapy program for Rett syndrome, high...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurogene-advances-rett-gene-therapy-program-and-extends-cash-runway-to-2029?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurogene-advances-rett-gene-therapy-program-and-extends-cash-runway-to-2029?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","SYNB","LFSC","CNCR","GNOM","TBXU","FBT","BK4588","IBBQ","IBB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":11,"totalSize":213,"code":"91000000","status":"200"}]}}